Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1266 |
|---|---|
| Identifier | NCT04209556 |
| Trial Title | A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: PF-06826647 100 mg QD|DRUG: PF-06826647 300 mg QD|DRUG: PF-06826647 600 mg QD|DRUG: Placebo|DRUG: PF-6826647 400 mg QD |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Canoga Park |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2020-09-30 |
|---|---|
| Primary Completion Date | 2023-10-26 |
| Completion Date | 2023-10-26 |